Advances and challenges in gene therapies (part 2)

Wednesday, September 14, 2022
PLENARY
14-PM-PLENARY 2:30 PM > 4:00 PM Advances and challenges in gene therapies (part 2) Apollon Auditorium

2:30 PM S12L1 X-linked myotubular myopathy and liver dysfunction > A. Ana BUJ-BELLO (Evry, France) 3:00 PM S12L2 Modelling and editing Duchenne Muscular Dystrophy > W-H. Wolfram-Hubertus ZIMMERMANN (Goettingen, Germany) 3:30 PM S12L3 Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 > G. Germana FALCONE (Monterotondo, Italy)

Copyright © key4events - All rights reserved